Publicaciones (433) Publicaciones en las que ha participado algún/a investigador/a

2024

  1. Biological Activity of 6,7-Dehydroxyroyleanone and Derivatives Obtained from Plectranthus aliciae (Codd) A.J.Paton

    ACS Omega, Vol. 9, Núm. 16, pp. 18113-18118

  2. Cardiovascular health and target end-organ damage and comorbidities in hypertensive patients from a Spanish primary care urban population

    Nefrologia, Vol. 44, Núm. 1, pp. 77-89

  3. Detection of binucleated nephrin-marked podocytes by flow cytometry in the urine of patients with obesity

    Journal of Nephrology

  4. Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial

    The Lancet Diabetes and Endocrinology, Vol. 12, Núm. 1, pp. 39-50

  5. Efficient and safe therapeutic use of paired Cas9-nickases for primary hyperoxaluria type 1

    EMBO molecular medicine, Vol. 16, Núm. 1, pp. 112-131

  6. Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

    The Lancet Diabetes and Endocrinology, Vol. 12, Núm. 1, pp. 51-60

  7. Induction of diabetes by Tacrolimus in a phenotypic model of obesity and metabolic syndrome

    Frontiers in Endocrinology, Vol. 15

  8. Insights into the pathogenesis of primary hyperoxaluria type I from the structural dynamics of alanine:glyoxylate aminotransferase variants

    FEBS Letters, Vol. 598, Núm. 4, pp. 485-499

  9. Integrated miRNA–mRNA Analysis Reveals Critical miRNAs and Targets in Diet-Induced Obesity-Related Glomerulopathy

    International Journal of Molecular Sciences, Vol. 25, Núm. 12

  10. International consensus on post-transplantation diabetes mellitus

    Nephrology Dialysis Transplantation

  11. Measured and Estimated Glomerular Filtration Rate to Evaluate Rapid Progression and Changes over Time in Autosomal Polycystic Kidney Disease: Potential Impact on Therapeutic Decision-Making

    International Journal of Molecular Sciences, Vol. 25, Núm. 9

  12. Modulation of the K/BxN arthritis mouse model and the effector functions of human fibroblast-like synoviocytes by liver X receptors

    European Journal of Immunology

  13. Multicenter Long-Term Real World Data on Treatment With Lumasiran in Patients With Primary Hyperoxaluria Type 1

    Kidney International Reports, Vol. 9, Núm. 1, pp. 114-133

  14. Postcolonoscopy colorectal cancer: Prevalence, categorization and root-cause analysis based on the World Endoscopic Organization system

    Gastroenterologia y Hepatologia, Vol. 47, Núm. 4, pp. 319-326

  15. Renal Disease in Metabolic Syndrome: the Hidden Role of Intrarenal Ischemia

    Kidney International Reports, Vol. 9, Núm. 5, pp. 1419-1428

  16. Restored glyoxylate metabolism after AGXT gene correction and direct reprogramming of primary hyperoxaluria type 1 fibroblasts

    iScience, Vol. 27, Núm. 4

  17. The error of estimated GFR in predialysis care

    Scientific Reports, Vol. 14, Núm. 1

  18. Therapeutic Exercise on Metabolic and Renal Outcomes in Patients with Chronic Kidney Disease: A Narrative Review

    Nephron, Vol. 148, Núm. 2, pp. 85-94

2023

  1. Appetite stimulation with cannabis-based medicine and methods for assessment of glomerular filtration in older patients with medical illness: A study protocol

    Basic and Clinical Pharmacology and Toxicology, Vol. 133, Núm. 3, pp. 237-253

  2. Association between Cardiovascular Health, C-Reactive Protein, and Comorbidities in Spanish Urban-Dwelling Overweight/Obese Hypertensive Patients

    Journal of Cardiovascular Development and Disease, Vol. 10, Núm. 7